Psychopharmacology & Medication Management Flashcards
7 cards from real LSP practice questions. Tap to flip, then mark Knew It or Still Learning — missed cards come back until you master them.
Read the first 7 Psychopharmacology & Medication Management flashcards as text
Which stimulant medication commonly prescribed for ADHD is classified as a Schedule II controlled substance?
Answer: Methylphenidate (Ritalin)
Methylphenidate is a CNS stimulant classified as Schedule II due to its high abuse potential, making it one of the most regulated ADHD medications.
Serotonin syndrome is a potentially life-threatening condition that most commonly occurs when:
Answer: Multiple serotonergic agents are combined
Serotonin syndrome results from excess serotonergic activity, typically triggered by combining medications that increase serotonin levels, such as SSRIs with MAOIs or triptans.
Which of the following is a key consideration when managing psychotropic medications in elderly clients?
Answer: Aging alters drug absorption, distribution, metabolism, and excretion, often requiring dose reductions
Age-related reductions in kidney and liver function, altered body composition, and changes in drug metabolism require lower doses and careful monitoring in elderly patients.
Tardive dyskinesia, characterized by involuntary repetitive movements, is a long-term side effect associated with prolonged use of:
Answer: Antipsychotic medications
Tardive dyskinesia results from long-term dopamine receptor blockade by antipsychotic medications, causing supersensitivity changes that produce involuntary movements.
In pharmacology, 'pharmacokinetics' refers to:
Answer: How the body absorbs, distributes, metabolizes, and excretes a drug
Pharmacokinetics describes what the body does to a drug through the four stages of absorption, distribution, metabolism, and excretion (ADME).
When a client on an atypical antipsychotic reports significant weight gain and elevated blood glucose, the psychologist should:
Answer: Consult with the prescribing physician about these metabolic side effects
Metabolic side effects like weight gain and hyperglycemia increase cardiovascular risk and must be communicated to the prescriber promptly to evaluate the need for medication adjustments.
Which medication received FDA approval for treatment-resistant depression and works through NMDA glutamate receptor antagonism?
Answer: Esketamine (Spravato)
Esketamine (Spravato), a nasal spray form of ketamine, received FDA approval for treatment-resistant depression and works by blocking NMDA glutamate receptors rather than monoamine systems.